Don't Be Surprised to See DOACs for Heparin-Induced Thrombocytopenia

April 2019

Heparin-induced thrombocytopenia (HIT) may be a new use for the direct oral anticoagulants (DOACs) apixaban and rivaroxaban.

Patients with HIT have low platelets...but they're prone to clots.

It's why these patients get started on argatroban, bivalirudin, or fondaparinux...then transition to warfarin.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Automated Dispensing Use the Latest Safety Strategies for Automated Dispensing Cabinets
Medication Errors Help Catch Duplicate Therapy Errors
Measles Be Prepared if a Measles Outbreak Brings Patients to Your Hospital
Infectious Diseases Anticipate More Orders for Colistin and Polymyxin B
Hyperkalemia Think of Lokelma as Similar to Kayexalate or Veltassa for High Potassium
Anticoagulants Don't Be Surprised to See DOACs for Heparin-Induced Thrombocytopenia
Nitrates Prevent Mix-Ups With Sublingual Nitroglycerin
Ulcerative Colitis Know How Meds for Ulcerative Colitis Stack Up
COPD Expect to Dispense a Formulary Alternative Instead of the New COPD Med, Yupelri
Anxiety Stay Alert for Common Errors With Anxiety Meds